Current Edition

deal

UCB to buy Zogenix for nearly $2B in ‘first step’ for M&A in 2022

Belgium’s UCB on Wednesday said it has agreed to acquire Zogenix for as much as $1.9 billion in a deal centered around an epilepsy drug …

Continue Reading →